Safety of Zein Nanoparticles on Human Innate Immunity and Inflammation


1. Introduction

One of the main successes of the nanotechnologies is the development of nano-based drug delivery systems. The use of nanoparticles (NPs) has allowed us to overcome the limitations of free therapeutics, facilitate the crossing of biological barriers and the entry into cells, and, recently, the development of precision medicine [1] and of new vaccines, such as those for COVID-19 [2].
Once inside the body, NPs readily come in contact with the immune system, and, in particular, with the innate immune cells, the first line of immune defense against foreign agents and particles. Such interaction can lead to different outcomes, depending on whether NPs are recognized as threats or not. In the first case, an inflammatory reaction is triggered, while in the second case NPs are silently eliminated (either digested or excreted). Silent elimination encompasses excretion through the kidneys, mainly but not exclusively for colloidal systems below 5 nm [3], and non-inflammatory uptake and digestion by the mononuclear phagocyte system, which depends on the size and chemical composition of the particles [4].
Thus, one of the main concerns when new nanomaterial-based therapeutics are developed is to establish their potential immunotoxicity and capacity to activate unwanted innate/inflammatory immune responses [5]. The evaluation of immunotoxicity is especially important in the case of drug delivery for two main reasons: 1. to avoid tissue damage due to a persistent particle-induced inflammatory response; 2. to avoid recognition and elimination of the nano-drugs by the innate immune system and the consequent abolishment of their therapeutic function [6]. The evaluation of the innate immune activation capacity is important especially in case of nano-vaccination, in order to facilitate antigen presentation and the initiation/amplification of adaptive immunity against a tumor or infection in a controlled fashion [7].
Natural polymers have attracted great interest for the development of release systems for active agents, and zein is one of the most widely used [8]. Zein is a hydrophobic proline-rich protein mixture obtained from maize and is an ideal material in drug delivery studies, as it is generally regarded as safe (GRAS), has a favorable profile of biocompatibility, biodegradability and low toxicity, and originates from a renewable source [9]. Zein can form low-cost biodegradable flexible films and resistant hydrophobic coatings, which provide protection against microbial attack, suggesting its suitability for producing micro/nanoparticles to be used as delivery systems for nutrients and drugs [10]. The structure of the protein, rich in nonpolar amino acid residues, is promoting its use as a component of future innovative pharmaceutical formulations, especially nanoparticulate drug delivery systems, aiming at modulating the therapeutic efficacy and pharmacokinetic profiles of the entrapped compounds [11,12]. The yellow zein (about 90% pure) contains 8–9% xanthophyll pigments, such as lutein, zeaxanthin, and β-cryptoxanthin, which increase the inherent antioxidant properties of zein, favoring its scavenging activity against free radicals and lipid peroxidation [13].
Despite the wide range of possible applications of zein in tissue engineering and the parenteral delivery of bioactive agents [10,14,15], only a few studies have assessed the immune activation induced by zein-based carrier systems [16,17]. In these studies, however, it was shown that zein micro- and nanoparticles can be immunogenic. For example, Hurtado-López and Murdan reported that intramuscular injection of the zein microspheres induced the production of anti-zein IgG, whereas oral administration induced a mucosal IgA (but not IgG) anti-zein response [17]. These data were also confirmed by Li and co-workers, who demonstrated that the administration of zein nanoparticles to mice by intramuscular or subcutaneous routes induces high levels of specific IgG antibodies in the circulation, independent of the NP size [16]. Besides these few reports pertaining to zein immunogenicity and triggering of adaptive immune responses, our understanding of the interaction between zein particles and the immune system is still largely incomplete. In particular, there is no information on their interaction with the innate immune system.
Besides a direct activation in response to microbial and other challenges, innate immune cells have the capacity of developing the so-called “innate memory”, which allows the pre-exposed (primed) cells to react differently to a subsequent challenge [18]. The secondary response of primed cells can be stronger (potentiation, trained immunity) or weaker (tolerance) compared with the first response, in order to obtain better protection and less side effects upon repeated challenges. Circulating peripheral blood monocytes are recruited to tissues, where they differentiate in macrophages, which are professional phagocytes and antigen-presenting cells. According to their functions, newly incoming monocytes and tissue macrophages can be broadly classified into inflammatory (classically activated, M1) and anti-inflammatory (healing, M2) subsets, which play distinct roles in the initiation and resolution of inflammation [19,20]. Polarization of human monocytes/macrophages into functionally different subsets occurs in response to endogenous and exogenous stimuli and varies depending on the changes in the microenvironmental conditions (with M1 cells becoming M2 and vice versa) [19,20]. In the presence of microbial agents and inflammatory cytokines, monocytes/macrophages polarize toward the M1 functional phenotype and release reactive oxygen and nitrogen species and inflammatory cytokines to eliminate the dangerous agents [21]. In contrast, healing M2 cells control and resolve inflammation by releasing anti-inflammatory cytokines and take part in tissue healing and remodeling [22].
In this study, we aimed to investigate the effects on the human innate immunity of zein stabilized with sodium cholate. Several works have already described the contribution of sodium cholate and its derivatives in the formation of stable colloidal NPs [23,24,25]. In fact, the use of specific surfactants in the development of novel formulations for (nano)vaccination can be profitable considering their inherent adjuvant properties [26] and their characteristics of absorption enhancers [27]. Moreover, these features can be exploited in order to enhance the uptake of the encapsulated antigen by the immune cells [28,29].

We have used human primary monocytes in vitro as a reliable model for assessing human innate immunity. We have evaluated the capacity of zein NPs to induce a primary innate/inflammatory response (measured as the balance between the induction of inflammatory and anti-inflammatory cytokines) and also their innate memory-inducing capacity. In addition, we have generated macrophages from blood monocytes, using an established in vitro differentiation system, and assessed the capacity of zein NPs to modulate the M1 and M2 macrophage polarization.

3. Materials and Methods

3.1. Preparation of Zein NPs

Yellow zein (CAS number 9010-66-62, MW 22–24 KDa) and sodium deoxycholate monohydrate (SD) were purchased from Merck Sigma-Aldrich® (Darmstadt, Germany).

Zein nanoparticles were obtained using the nanoprecipitation technique as previously reported [35]. Briefly, zein (10 mg/mL) in 3 mL of an ethanol/aqueous solution (2:1 v/v) was added with 5 mL MilliQ water alone or containing 12.5 mg/mL of the anionic surfactant SD at room temperature. The obtained suspension was homogenized for 1 min with an Ultraturrax® (model T25, IKA® Werke, Staufen, Germany) at 24,000 rpm and then mechanically stirred at 600 rpm for 12 h to promote the evaporation of the organic solvent. The final zein concentration was 2 mg/mL. Subsequently, the NPs were purified using Amicon® Ultra centrifugal filters, Sigma-Aldrich (cut-off 10 kDa, 4000 rpm for 120 min) for the in vitro experiments. NPs were resuspended in different media, based on the experiments to be performed [36].

3.2. Physical–Chemical Characterization of Zein NPs

The physical–chemical parameters of NPs such as the mean diameter, size distribution, and zeta potential were investigated via photon correlation spectroscopy (Zetasizer NanoZS, Malvern Panalytical Ltd., Spectris plc, Great Marvern, UK) with an applied third order cumulant fitting correlation function. The results are expressed as a function of the intensity parameter and are the means of three different measurements carried out in triplicate (10 determinations for each replicate) on three different samples ± standard deviation.

The kinetic stability of the formulations was investigated using the Turbiscan Lab Expert® analyzer (Formulaction, Toulouse, France) as a function of temperature and incubation time, as previously described [35]. The data were processed by a Turby Soft 2.0 and reported as the Turbiscan Stability Index (TSI) versus time.
To assess the behavior of zein NPs in the presence of biological fluids, zein NPs were exposed to human serum at 37 °C. Briefly, 20 µL of purified NPs (400 μg of protein) was added to 1 mL of 70% AB serum heat-inactivated, and the resulting suspension was incubated at 37 °C for 24 h under stirring. The average diameter of the samples was analyzed at different incubation times as described [37].

3.3. Biocorona Formation on Zein NPs

Before addition to cell culture, zein NPs were pre-incubated in 50% heat-inactivated human AB serum (Sigma-Aldrich) at 37 °C for 1 h under stirring in order to obtain the formation of a serum biocorona on the surface, thereby ensuring particle stability in culture. The serum–NPs mixture was then added directly to culture wells, adjusting NP and serum concentration to the desired values for each treatment.

3.4. Human Monocyte Isolation

Buffy coats collected in bags with sodium citrate as anticoagulant were obtained from six healthy donors, upon informed consent. The procedure was in agreement with the Declaration of Helsinki, and the protocol was approved by the Regional Ethics Committee for Clinical Experimentation of the Tuscany Region (Ethics Committee Register n. 14,914 of 16 May 2019).

Monocytes were isolated by CD14 positive selection with magnetic microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany) from peripheral blood mononuclear cells (PBMC), obtained via Ficoll-Paque gradient density separation (GE Healthcare, Bio-Sciences AB, Uppsala, Sweden). Monocyte preparations used in the experiments were > 95% viable and >95% pure (assessed by trypan blue exclusion and cytosmears).

Monocytes (5 × 105 cells/well) were cultured in RPMI-1640 medium + Glutamax™ (GIBCO™, ThermoFisher Scientific, Waltham, MA, USA) supplemented with 50 μg/mL gentamicin sulfate (GIBCO), 5% heat-inactivated human AB serum (Merck Sigma-Aldrich®), and 10 ng/mL CSF-1 (Merck Sigma-Aldrich®) in a final volume of 1.0 mL in wells of 24-well flat bottom plates (Corning Costar, Corning Inc. Life Sciences, Oneonta, NY, USA). The cells are maintained at 37 °C in a 5% CO2 atmosphere. Monocyte stimulation was performed after overnight resting.

3.5. Human Monocyte Activation and Induction of Innate Memory

For assessing the primary innate/inflammatory response, monocytes were exposed for 24 h to culture medium alone (medium/negative control) or containing 1 ng/mL LPS (positive control; from E. coli O55:B5; Merck Sigma-Aldrich®), serum pre-coated zein NPs, and the mixture LPS + zein NPs.

For the memory experiments, after the first exposure to stimuli for 24 h and supernatant collection, cells were washed and cultured for 7 additional days, the medium refreshed every 3 days. During this period (resting phase), the activation induced by previous stimulation subsided, and cells returned to their baseline status. This was previously determined by the lack of production/release of inflammation-related cytokines (mRNA and proteins) in time course experiments. After the resting phase, the supernatant was replaced with fresh medium alone or containing 5 ng/mL LPS, and incubation was carried out for 24 h (challenge).

All supernatants (after the first stimulation, after the resting phase, and after challenge) were frozen at −80 °C for subsequent cytokine analysis.

Cell viability was monitored during the entire course of culture by visual inspection (viable cell counting in phase contrast optical microscopy). No visible changes in the cell number and viability were identified in response to the different treatments. Duplicate samples were prepared for each experimental condition.

3.6. Human Monocyte-Derived Macrophages Activation and Polarization

Monocytes were cultured in complete culture in the presence of 10 ng/mL CSF-1 (Merck Sigma-Aldrich®) in a final volume of 1.0 mL in wells of 24-well flat bottom plates (Corning Costar). The cells were maintained at 37 °C in a 5% CO2 atmosphere for 7 days to allow spontaneous monocyte differentiation into resting naïve macrophages. The culture medium was refreshed every three days. On day 8, the supernatant was removed, and naïve macrophages were polarized toward M1 or M2 in the absence or presence of 100 ng/mL of zein NPs. M1 polarization was obtained by incubation for 24 h with LPS (10 ng/mL) and human recombinant IFN-γ (20 ng/mL; R&D Systems, Minneapolis, MN, USA). M2 polarization was obtained by adding human recombinant IL-10 (20 ng/mL; R&D Systems) for 24 h. Control naïve macrophages were incubated for 24 h in culture medium alone. Supernatants were collected and frozen at −80 °C for subsequent cytokine analysis.

Cell viability was monitored during the entire course of culture by visual inspection. No visible changes in the cell number and viability were identified in response to the different treatments. Duplicate samples were prepared for each experimental condition.

3.7. Analysis of Surface Markers on Monocyte-Derived Macrophages

Surface markers of naïve, M1, and M2 macrophages were assessed using an immunofluorescent antibody-labeling technique. At the end of the differentiation and polarization period, monocyte-derived macrophages were washed twice in PBS and processed as follows. For the immunofluorescent analysis of CD80 (a costimulatory protein expressed on professional antigen-presenting cells including macrophages), the samples were fixed with 4% paraformaldehyde for 15 min, permeabilized with 0.25% Triton X100/PBS, blocked with 2% BSA/PBS (30 min at RT), incubated with an anti-CD80 (B7-1) rabbit polyclonal antibody (cat. PA5-85913, Invitrogen, Waltham, MA, USA) diluted 1:100 (o/n at 4 °C), and then with a goat anti-rabbit IgG labeled with Alexa Fluor 568 (red) (30 min at RT). For the analysis of CD206 (a protein expressed on human macrophages and generally used as a marker for detecting M2 macrophages), the samples were fixed with 4% paraformaldehyde for 15 min, permeabilized with 0.1% Triton X-100/PBS, blocked with 10% serum/PBS (45 min at RT), incubated with an anti-CD206 rabbit polyclonal antibody (cat. PA5-101657, Invitrogen) diluted 1:200 (o/n at 4 °C), and then with a goat anti-rabbit IgG labeled with Alexa Fluor 568 (red) (30 min at RT). For the analysis of the Mature Macrophage Marker 25F9 (a protein present on mature macrophages both on the cell surface and in intracellular vesicular structures), the samples were fixed with acetone for 15 min at RT, blocked with 2% BSA/PBS (30 min at RT), incubated with an anti-Mature Macrophage Marker mouse monoclonal IgG antibody (eBio25F9 (25F9), cat. 14-0115-82 eBioscience, Invitrogen) diluted 1:100 (o/n at 4 °C), and then with a goat anti-mouse IgG labeled with Alexa Fluor 568 (red) (30 min at RT). For all the samples, nuclei were stained with Hoechst 33258 (blue). Eventually, cells were washed three times in PBS and once in sterile water to remove salts. Coverslips were then mounted on glass microscope slides with Mowiol. Immunolocalization of 25F9, CD80, and CD206 was visualized and images were obtained using a Zeiss LSM700 laser-scanning confocal microscope with a 63× oil-immersion objective (Zeiss, Jena, Germany).

3.8. Evaluation of Zein Uptake

Monocyte-derived macrophages, plated on glass coverslips at the density of 2 × 105 cells/slide, were treated with rhodamine labeled-zein NPs (25 ng/mL) for different time periods (30′, 2 h, 6 h, 24 h). At the end of each experimental time, cells were washed twice in PBS, fixed with 4% paraformaldehyde for 10 min, incubated with Hoechst 33258 to label the nuclei, and washed three times in PBS and once in sterile water to remove salts. Coverslips were then mounted on glass microscope slides with Mowiol. Localization of zein NPs was visualized, and images were obtained using a Zeiss LSM700 laser-scanning confocal microscope with a 63× oil-immersion objective (Zeiss, Jena, Germany).

3.9. Evaluation of Cytokine Production

Production of cytokines was measured in the culture supernatants via ELISA (R&D Systems, Inc., Minneapolis, MN, USA) using a MultiScan FC reader (ThermoScientific, Waltham, MA, USA) according to the manufacturer’s instructions. Two ELISA replicates were run for each sample.

3.10. Statistical Analysis

Cytokine levels are presented as ng per million input monocytes. Graphical presentations and statistical analysis were performed using GraphPad Prism 9 (GraphPad Inc., La Jolla, CA, USA).

Data are shown as averages of biological duplicates or as averages of technical replicates of biological duplicates, and results are reported as mean + standard deviation (sd) of values. Statistical analysis was carried out using a one-way ANOVA unpaired with the Dunnett test for multiple comparisons. For polarization experiments, a one-way ANOVA unpaired with the Bonferroni test was used.



Source link

Annunziata Corteggio www.mdpi.com